Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Hum Mol Genet ; 30(3-4): 135-148, 2021 04 26.
Artículo en Inglés | MEDLINE | ID: mdl-33432339

RESUMEN

Huntington's disease pathogenesis involves a genetic gain-of-function toxicity mechanism triggered by the expanded HTT CAG repeat. Current therapeutic efforts aim to suppress expression of total or mutant huntingtin, though the relationship of huntingtin's normal activities to the gain-of-function mechanism and what the effects of huntingtin-lowering might be are unclear. Here, we have re-investigated a rare family segregating two presumed HTT loss-of-function (LoF) variants associated with the developmental disorder, Lopes-Maciel-Rodan syndrome (LOMARS), using whole-genome sequencing of DNA from cell lines, in conjunction with analysis of mRNA and protein expression. Our findings correct the muddled annotation of these HTT variants, reaffirm they are the genetic cause of the LOMARS phenotype and demonstrate that each variant is a huntingtin hypomorphic mutation. The NM_002111.8: c.4469+1G>A splice donor variant results in aberrant (exon 34) splicing and severely reduced mRNA, whereas, surprisingly, the NM_002111.8: c.8157T>A NP_002102.4: Phe2719Leu missense variant results in abnormally rapid turnover of the Leu2719 huntingtin protein. Thus, although rare and subject to an as yet unknown LoF intolerance at the population level, bona fide HTT LoF variants can be transmitted by normal individuals leading to severe consequences in compound heterozygotes due to huntingtin deficiency.


Asunto(s)
Regulación de la Expresión Génica , Proteína Huntingtina/genética , Mutación , Trastornos del Neurodesarrollo/genética , Secuencia de Aminoácidos , Línea Celular , Niño , Preescolar , Femenino , Humanos , Proteína Huntingtina/química , Proteína Huntingtina/metabolismo , Mutación con Pérdida de Función , Masculino , Mutación Missense , Trastornos del Neurodesarrollo/metabolismo , Linaje , Fenotipo , Empalme del ARN , ARN Mensajero/genética , ARN Mensajero/metabolismo , Alineación de Secuencia , Análisis de Secuencia de ADN
2.
Hum Mol Genet ; 26(7): 1258-1267, 2017 04 01.
Artículo en Inglés | MEDLINE | ID: mdl-28165127

RESUMEN

Huntington's disease (HD) reflects dominant consequences of a CAG repeat expansion mutation in HTT. Expanded CAG repeat size is the primary determinant of age at onset and age at death in HD. Although HD pathogenesis is driven by the expanded CAG repeat, whether the mutation influences the expression levels of mRNA and protein from the disease allele is not clear due to the lack of sensitive allele-specific quantification methods and the presence of confounding factors. To determine the impact of CAG expansion at the molecular level, we have developed novel allele-specific HTT mRNA and protein quantification methods based on principles of multiplex ligation-dependent probe amplification and targeted MS/MS parallel reaction monitoring, respectively. These assays, exhibiting high levels of specificity and sensitivity, were designed to distinguish allelic products based upon expressed polymorphic variants in HTT, including rs149 109 767. To control for other cis-haplotype variations, we applied allele-specific quantification assays to a panel of HD lymphoblastoid cell lines, each carrying the major European disease haplotype (i.e. hap.01) on the mutant chromosome. We found that steady state levels of HTT mRNA and protein were not associated with expanded CAG repeat length. Rather, the products of mutant and normal alleles, both mRNA and protein, were balanced, thereby arguing that a cis-regulatory effect of the expanded CAG repeat is not a critical component of the underlying mechanism of HD. These robust allele-specific assays could prove valuable for monitoring the impact of allele-specific gene silencing strategies currently being explored as therapeutic interventions in HD.


Asunto(s)
Encéfalo/metabolismo , Proteína Huntingtina/biosíntesis , Enfermedad de Huntington/genética , Expansión de Repetición de Trinucleótido/genética , Adulto , Edad de Inicio , Alelos , Autopsia , Encéfalo/patología , Femenino , Regulación de la Expresión Génica , Humanos , Proteína Huntingtina/genética , Enfermedad de Huntington/patología , Masculino , ARN Mensajero/biosíntesis
3.
Structure ; 28(9): 1035-1050.e8, 2020 09 01.
Artículo en Inglés | MEDLINE | ID: mdl-32668197

RESUMEN

The polyQ expansion in huntingtin protein (HTT) is the prime cause of Huntington's disease (HD). The recent cryoelectron microscopy (cryo-EM) structure of HTT-HAP40 complex provided the structural information on its HEAT-repeat domains. Here, we present analyses of the impact of polyQ length on the structure and function of HTT via an integrative structural and biochemical approach. The cryo-EM analysis of normal (Q23) and disease (Q78) type HTTs shows that the structures of apo HTTs significantly differ from the structure of HTT in a HAP40 complex and that the polyQ expansion induces global structural changes in the relative movements among the HTT domains. In addition, we show that the polyQ expansion alters the phosphorylation pattern across HTT and that Ser2116 phosphorylation in turn affects the global structure and function of HTT. These results provide a molecular basis for the effect of the polyQ segment on HTT structure and activity, which may be important for HTT pathology.


Asunto(s)
Proteína Huntingtina/química , Proteína Huntingtina/metabolismo , Péptidos/metabolismo , Microscopía por Crioelectrón , Humanos , Proteína Huntingtina/genética , Espectrometría de Masas de Intercambio de Hidrógeno-Deuterio , Espectrometría de Masas , Modelos Moleculares , Mutación , Péptidos/química , Fosforilación , Dominios Proteicos , Dispersión del Ángulo Pequeño , Serina/metabolismo , Difracción de Rayos X
4.
Mol Ther Nucleic Acids ; 11: 416-428, 2018 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-29858077

RESUMEN

The CAG repeat expansion that elongates the polyglutamine tract in huntingtin is the root genetic cause of Huntington's disease (HD), a debilitating neurodegenerative disorder. This seemingly slight change to the primary amino acid sequence alters the physical structure of the mutant protein and alters its activity. We have identified a set of G-quadruplex-forming DNA aptamers (MS1, MS2, MS3, MS4) that bind mutant huntingtin proximal to lysines K2932/K2934 in the C-terminal CTD-II domain. Aptamer binding to mutant huntingtin abrogated the enhanced polycomb repressive complex 2 (PRC2) stimulatory activity conferred by the expanded polyglutamine tract. In HD, but not normal, neuronal progenitor cells (NPCs), MS3 aptamer co-localized with endogenous mutant huntingtin and was associated with significantly decreased PRC2 activity. Furthermore, MS3 transfection protected HD NPCs against starvation-dependent stress with increased ATP. Therefore, DNA aptamers can preferentially target mutant huntingtin and modulate a gain of function endowed by the elongated polyglutamine segment. These mutant huntingtin binding aptamers provide novel molecular tools for delineating the effects of the HD mutation and encourage mutant huntingtin structure-based approaches to therapeutic development.

5.
Elife ; 5: e11184, 2016 Mar 22.
Artículo en Inglés | MEDLINE | ID: mdl-27003594

RESUMEN

The polyglutamine expansion in huntingtin protein causes Huntington's disease. Here, we investigated structural and biochemical properties of huntingtin and the effect of the polyglutamine expansion using various biophysical experiments including circular dichroism, single-particle electron microscopy and cross-linking mass spectrometry. Huntingtin is likely composed of five distinct domains and adopts a spherical α-helical solenoid where the amino-terminal and carboxyl-terminal regions fold to contain a circumscribed central cavity. Interestingly, we showed that the polyglutamine expansion increases α-helical properties of huntingtin and affects the intramolecular interactions among the domains. Our work delineates the structural characteristics of full-length huntingtin, which are affected by the polyglutamine expansion, and provides an elegant solution to the apparent conundrum of how the extreme amino-terminal polyglutamine tract confers a novel property on huntingtin, causing the disease.


Asunto(s)
Proteína Huntingtina/química , Proteína Huntingtina/metabolismo , Péptidos/metabolismo , Fenómenos Biofísicos , Dicroismo Circular , Espectrometría de Masas , Microscopía Electrónica , Conformación Proteica
6.
PLoS One ; 9(6): e98650, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24915567

RESUMEN

Nuclear inclusion a (NIa) of turnip mosaic virus is a cytosolic protease that cleaves amyloid ß (Aß) when heterologously overexpressed. Lentivirus-mediated expression of NIa in the brains of APP(sw)/PS1 mice significantly reduces cerebral Aß levels and plaque depositions, and improves behavioral deficits. Here, the effects of NIa and neprilysin (NEP), a well-known Aß-cleaving protease, on oligomeric Aß-induced cell death were evaluated. NIa cleaved monomeric and oligomeric Aß at a similar rate, whereas NEP only cleaved monomeric Aß. Oligomeric Aß-induced cytotoxicity and mitochondrial dysfunction were significantly ameliorated by NIa, but not by NEP. Endocytosed fluorescently-labeled Aß localized to mitochondria, and this was significantly reduced by NIa, but not by NEP. These data suggest that NIa may exerts its protective roles by degrading Aß and thus preventing mitochondrial deposition of Aß.


Asunto(s)
Péptidos beta-Amiloides/metabolismo , Endopeptidasas/metabolismo , Proteínas Virales/metabolismo , Péptidos beta-Amiloides/química , Péptidos beta-Amiloides/toxicidad , Línea Celular , ARN Polimerasas Dirigidas por ADN/metabolismo , Humanos , Espacio Intracelular/metabolismo , Mitocondrias/metabolismo , Multimerización de Proteína , Proteolisis
7.
Int J Biol Sci ; 9(8): 778-91, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23983611

RESUMEN

We previously reported a novel interaction between v-Crk and myosin-1c, and demonstrated that this interaction is essential for cell migration, even in the absence of p130CAS. We here demonstrate a role for Crk-myosin-1c interaction in cell adhesion and spreading. Crk-knockout (Crk ⁻/⁻) mouse embryo fibroblasts (MEFs) exhibited significantly decreased cell spreading and reduced Rac1 activity. A stroboscopic analysis of cell dynamics during cell spreading revealed that the cell-spreading deficiency in Crk⁻/⁻ MEFs was due to the short protrusion/retraction distances and long persistence times of membrane extensions. The low activity of Rac1 in Crk⁻/⁻ MEFs, which led to delayed cell spreading in these cells, is consistent with the observed defects in membrane dynamics. Reintroduction of v-Crk into Crk⁻/⁻ MEFs rescued these defects, restoring cell-spreading activity and membrane dynamics to Crk⁺/⁺ MEF levels, and normalizing Rac1 activity. Knockdown of myosin-1c by introduction of small interfering RNA resulted in a delay in cell spreading and reduced Rac1 activity to low levels, suggesting that myosin-1c also plays an essential role in cell adhesion and spreading. In addition, deletion of the v-Crk SH3 domain, which interacts with the myosin-1c tail, led to defects in cell spreading. Overexpression of the GFP-myosin-1c tail domain effectively inhibited the v-Crk-myosin-1c interaction and led to a slight decrease in cell spreading and cell surface area. Collectively, these findings suggest that the v-Crk-myosin-1c interaction, which modulates membrane dynamics by regulating Rac1 activity, is crucial for cell adhesion and spreading.


Asunto(s)
Adhesión Celular/fisiología , Membrana Celular/fisiología , Movimiento Celular/fisiología , Fibronectinas/metabolismo , Miosina Tipo I/metabolismo , Proteínas Proto-Oncogénicas c-crk/metabolismo , Animales , Adhesión Celular/genética , Movimiento Celular/genética , Cartilla de ADN/genética , Fibroblastos , Técnicas de Silenciamiento del Gen , Immunoblotting , Inmunohistoquímica , Ratones , Ratones Noqueados , Miosina Tipo I/genética , Neuropéptidos/metabolismo , Proteínas Proto-Oncogénicas c-crk/genética , ARN Interferente Pequeño/genética , Estroboscopía , Proteína de Unión al GTP rac1/metabolismo
8.
PLoS One ; 8(12): e82610, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24340049

RESUMEN

The finding that SPIN90 colocalizes with epidermal growth factor (EGF) in EEA1-positive endosomes prompted us to investigate the role of SPIN90 in endocytosis of the EGF receptor (EGFR). In the present study, we demonstrated that SPIN90 participates in the early stages of endocytosis, including vesicle formation and trafficking. Stable HeLa cells with knockdown of SPIN90 displayed significantly higher levels of surface EGFR than control cells. Analysis of the abundance and cellular distribution of EGFR via electron microscopy revealed that SPIN90 knockdown cells contain residual EGFR at cell membranes and fewer EGFR-containing endosomes, both features that reflect reduced endosome formation. The delayed early endosomal targeting capacity of SPIN90 knockdown cells led to increased EGFR stability, consistent with the observed accumulation of EGFR at the membrane. Small endosome sizes and reduced endosome formation in SPIN90 knockdown cells, observed using fluorescent confocal microscopy, strongly supported the involvement of SPIN90 in endocytosis of EGFR. Overexpression of SPIN90 variants, particularly the SH3, PRD, and CC (positions 643 - 722) domains, resulted in aberrant morphology of Rab5-positive endosomes (detected as small spots located near the cell membrane) and defects in endosomal movement. These findings clearly suggest that SPIN90 participates in the formation and movement of endosomes. Consistent with this, SPIN90 knockdown enhanced cell proliferation. The delay in EGFR endocytosis effectively increased the levels of endosomal EGFR, which triggered activation of ERK1/2 and cell proliferation via upregulation of cyclin D1. Collectively, our findings suggest that SPIN90 contributes to the formation and movement of endosomal vesicles, and modulates the stability of EGFR protein, which affects cell cycle progression via regulation of the activities of downstream proteins, such as ERK1/2, after EGF stimulation.


Asunto(s)
Proteínas Adaptadoras Transductoras de Señales/metabolismo , Ciclo Celular/fisiología , Endocitosis/fisiología , Endosomas/metabolismo , Receptores ErbB/metabolismo , Membranas Intracelulares/metabolismo , Proteínas Musculares/metabolismo , Proteínas Adaptadoras Transductoras de Señales/genética , Transporte Biológico Activo/fisiología , Ciclina D1/biosíntesis , Ciclina D1/genética , Endosomas/genética , Receptores ErbB/genética , Técnicas de Silenciamiento del Gen , Células HeLa , Humanos , Proteína Quinasa 1 Activada por Mitógenos/genética , Proteína Quinasa 1 Activada por Mitógenos/metabolismo , Proteína Quinasa 3 Activada por Mitógenos/genética , Proteína Quinasa 3 Activada por Mitógenos/metabolismo , Proteínas Musculares/genética , Regulación hacia Arriba/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA